Cargando…
Emerging strategies for cancer therapy by ATR inhibitors
DNA replication stress (RS) causes genomic instability and vulnerability in cancer cells. To counteract RS, cells have evolved various mechanisms involving the ATR kinase signaling pathway, which regulates origin firing, cell cycle checkpoints, and fork stabilization to secure the fidelity of replic...
Autores principales: | Yano, Kimiyoshi, Shiotani, Bunsyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323102/ https://www.ncbi.nlm.nih.gov/pubmed/37189251 http://dx.doi.org/10.1111/cas.15845 |
Ejemplares similares
-
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress
por: Igarashi, Taichi, et al.
Publicado: (2023) -
PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA
por: Yano, Kimiyoshi, et al.
Publicado: (2021) -
SMARCA4 deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma
por: Kurashima, Kiminori, et al.
Publicado: (2020) -
Progress towards a clinically-successful ATR inhibitor for cancer therapy
por: Barnieh, Francis M., et al.
Publicado: (2021) -
Prospects for the Use of ATR Inhibitors to Treat Cancer
por: Wagner, Jill M., et al.
Publicado: (2010)